Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Pharmacology of a central nervous system delivered 2'-O-methoxyethyl-modified survival of motor neuron splicing oligonucleotide in mice and nonhuman primatesThe Journal of pharmacology and experimental therapeutics, 2014-07, Vol.350 (1), p.46-55 [Peer Reviewed Journal]Copyright © 2014 by The American Society for Pharmacology and Experimental Therapeutics. ;Copyright © 2014 by The American Society for Pharmacology and Experimental Therapeutics 2014 ;ISSN: 0022-3565 ;EISSN: 1521-0103 ;DOI: 10.1124/jpet.113.212407 ;PMID: 24784568Full text available |
|
2 |
Material Type: Article
|
CpG DNA as a vaccine adjuvantExpert review of vaccines, 2011-04, Vol.10 (4), p.499-511 [Peer Reviewed Journal]Expert Reviews Ltd 2011 ;COPYRIGHT 2011 Expert Reviews Ltd. ;ISSN: 1476-0584 ;EISSN: 1744-8395 ;DOI: 10.1586/erv.10.174 ;PMID: 21506647Full text available |
|
3 |
Material Type: Article
|
Enhancing immunomodulation on innate immunity by shape transition among RNA triangle, square and pentagon nanovehiclesNucleic acids research, 2014-09, Vol.42 (15), p.9996-10004 [Peer Reviewed Journal]The Author(s) 2014. Published by Oxford University Press on behalf of Nucleic Acids Research. ;The Author(s) 2014. Published by Oxford University Press on behalf of Nucleic Acids Research. 2014 ;ISSN: 0305-1048 ;EISSN: 1362-4962 ;DOI: 10.1093/nar/gku516 ;PMID: 25092921Full text available |
|
4 |
Material Type: Article
|
Structure-dependent immunostimulatory effect of CpG oligodeoxynucleotides and their delivery systemInternational Journal of Nanomedicine, 2012-01, Vol.7 (default), p.2181-2195 [Peer Reviewed Journal]2012. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2012 Hanagata, publisher and licensee Dove Medical Press Ltd. 2012 ;ISSN: 1178-2013 ;ISSN: 1176-9114 ;EISSN: 1178-2013 ;DOI: 10.2147/IJN.S30197 ;PMID: 22619554Full text available |
|
5 |
Material Type: Article
|
A phase II trial of AS1411 (a novel nucleolin-targeted DNA aptamer) in metastatic renal cell carcinomaInvestigational new drugs, 2014-02, Vol.32 (1), p.178-187 [Peer Reviewed Journal]Springer Science+Business Media New York 2013 ;2015 INIST-CNRS ;Springer Science+Business Media New York 2014 ;ISSN: 0167-6997 ;EISSN: 1573-0646 ;DOI: 10.1007/s10637-013-0045-6 ;PMID: 24242861 ;CODEN: INNDDKFull text available |
|
6 |
Material Type: Article
|
An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man studyLancet neurology, 2013-05, Vol.12 (5), p.435-442 [Peer Reviewed Journal]Elsevier Ltd ;2013 Elsevier Ltd ;Copyright © 2013 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited May 2013 ;ISSN: 1474-4422 ;EISSN: 1474-4465 ;DOI: 10.1016/S1474-4422(13)70061-9 ;PMID: 23541756 ;CODEN: LANCAOFull text available |
|
7 |
Material Type: Article
|
Vaccination with NY-ESO-1 protein and CpG in Montanide induces integrated antibody/Th1 responses and CD8 T cells through cross-primingProceedings of the National Academy of Sciences - PNAS, 2007-05, Vol.104 (21), p.8947-8952 [Peer Reviewed Journal]Copyright 2007 The National Academy of Sciences of the United States of America ;Copyright National Academy of Sciences May 22, 2007 ;2007 by The National Academy of Sciences of the USA 2007 ;ISSN: 0027-8424 ;EISSN: 1091-6490 ;DOI: 10.1073/pnas.0703395104 ;PMID: 17517626Full text available |
|
8 |
Material Type: Article
|
Targeting noncoding RNAs in diseaseThe Journal of clinical investigation, 2017-03, Vol.127 (3), p.761-771 [Peer Reviewed Journal]COPYRIGHT 2017 American Society for Clinical Investigation ;Copyright American Society for Clinical Investigation Mar 2017 ;Copyright © 2017, American Society for Clinical Investigation 2017 American Society for Clinical Investigation ;ISSN: 0021-9738 ;EISSN: 1558-8238 ;DOI: 10.1172/JCI84424 ;PMID: 28248199Full text available |
|
9 |
Material Type: Article
|
Renal Effects of Antisense-Mediated Inhibition of SGLT2The Journal of pharmacology and experimental therapeutics, 2016-11, Vol.359 (2), p.280-289 [Peer Reviewed Journal]Copyright © 2016 by The Author(s). ;ISSN: 0022-3565 ;EISSN: 1521-0103 ;DOI: 10.1124/jpet.116.233809 ;PMID: 27605629Full text available |
|
10 |
Material Type: Article
|
Randomized, placebo-controlled trial of mipomersen in patients with severe hypercholesterolemia receiving maximally tolerated lipid-lowering therapyPloS one, 2012-11, Vol.7 (11), p.e49006 [Peer Reviewed Journal]COPYRIGHT 2012 Public Library of Science ;COPYRIGHT 2012 Public Library of Science ;2012 McGowan et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: https://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2012 McGowan et al 2012 McGowan et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0049006 ;PMID: 23152839Full text available |
|
11 |
Material Type: Article
|
Local Adjuvant Treatment with Low-Dose CpG-B Offers Durable Protection against Disease Recurrence in Clinical Stage I-II Melanoma: Data from Two Randomized Phase II TrialsClinical cancer research, 2017-10, Vol.23 (19), p.5679-5686 [Peer Reviewed Journal]2017 American Association for Cancer Research. ;Copyright American Association for Cancer Research Inc Oct 1, 2017 ;ISSN: 1078-0432 ;EISSN: 1557-3265 ;DOI: 10.1158/1078-0432.CCR-17-0944 ;PMID: 28972083Full text available |
|
12 |
Material Type: Article
|
B Cells Produce Type 1 IFNs in Response to the TLR9 Agonist CpG-A Conjugated to Cationic LipidsThe Journal of immunology (1950), 2017-08, Vol.199 (3), p.931-940 [Peer Reviewed Journal]Copyright © 2017 by The American Association of Immunologists, Inc. ;Copyright American Association of Immunologists Aug 1, 2017 ;ISSN: 0022-1767 ;EISSN: 1550-6606 ;DOI: 10.4049/jimmunol.1700348 ;PMID: 28652397Full text available |
|
13 |
Material Type: Article
|
Therapeutic Targeting of TLR9 Inhibits Cell Growth and Induces Apoptosis in NeuroblastomaCancer research (Chicago, Ill.), 2010-12, Vol.70 (23), p.9816-9826 [Peer Reviewed Journal]2015 INIST-CNRS ;ISSN: 0008-5472 ;EISSN: 1538-7445 ;DOI: 10.1158/0008-5472.can-10-1251 ;PMID: 20935225 ;CODEN: CNREA8Full text available |
|
14 |
Material Type: Article
|
Nonagonistic Dectin-1 ligand transforms CpG into a multitask nanoparticulate TLR9 agonistProceedings of the National Academy of Sciences - PNAS, 2014-02, Vol.111 (8), p.3086-3091 [Peer Reviewed Journal]copyright © 1993–2008 National Academy of Sciences of the United States of America ;Copyright National Academy of Sciences Feb 25, 2014 ;ISSN: 0027-8424 ;EISSN: 1091-6490 ;DOI: 10.1073/pnas.1319268111 ;PMID: 24516163Full text available |
|
15 |
Material Type: Article
|
Discovery and development of anticancer aptamersMolecular cancer therapeutics, 2006-12, Vol.5 (12), p.2957-2962 [Peer Reviewed Journal]ISSN: 1535-7163 ;EISSN: 1538-8514 ;DOI: 10.1158/1535-7163.MCT-06-0172 ;PMID: 17172400Full text available |
|
16 |
Material Type: Article
|
Serum-resistant CpG-STAT3 decoy for targeting survival and immune checkpoint signaling in acute myeloid leukemiaBlood, 2016-03, Vol.127 (13), p.1687-1700 [Peer Reviewed Journal]2016 American Society of Hematology ;2016 by The American Society of Hematology. ;2016 by The American Society of Hematology 2016 ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2015-08-665604 ;PMID: 26796361Full text available |
|
17 |
Material Type: Article
|
DEC-205 is a cell surface receptor for CpG oligonucleotidesProceedings of the National Academy of Sciences - PNAS, 2012-10, Vol.109 (40), p.16270-16275 [Peer Reviewed Journal]copyright © 1993-2008 National Academy of Sciences of the United States of America ;ISSN: 0027-8424 ;EISSN: 1091-6490 ;DOI: 10.1073/pnas.1208796109 ;PMID: 22988114Full text available |
|
18 |
Material Type: Article
|
Plasma Membrane Nucleolin Is a Receptor for the Anticancer Aptamer AS1411 in MV4-11 Leukemia CellsMolecular pharmacology, 2009-11, Vol.76 (5), p.984-991 [Peer Reviewed Journal]2009 The American Society for Pharmacology and Experimental Therapeutics ;ISSN: 0026-895X ;EISSN: 1521-0111 ;DOI: 10.1124/mol.109.055947 ;PMID: 19657047Full text available |
|
19 |
Material Type: Article
|
Programmable multistage drug delivery to lymph nodesNature nanotechnology, 2020-06, Vol.15 (6), p.491-499 [Peer Reviewed Journal]The Author(s), under exclusive licence to Springer Nature Limited 2020. ;ISSN: 1748-3387 ;EISSN: 1748-3395 ;DOI: 10.1038/s41565-020-0679-4 ;PMID: 32523099Full text available |
|
20 |
Material Type: Article
|
Sustained Therapeutic Reversal of Huntington's Disease by Transient Repression of Huntingtin SynthesisNeuron (Cambridge, Mass.), 2012-06, Vol.74 (6), p.1031-1044 [Peer Reviewed Journal]2012 Elsevier Inc. ;Copyright © 2012 Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Jun 21, 2012 ;2012 Elsevier Inc. All rights reserved. 2012 ;ISSN: 0896-6273 ;EISSN: 1097-4199 ;DOI: 10.1016/j.neuron.2012.05.009 ;PMID: 22726834Full text available |